A high prevalence of VPAC2 receptors was detected in some of the most frequently occurring carcinomas, including gastric cancer, pancreatic ductal adenocarcinoma, small-cell lung carcinoma and thyroid carcinoma. The gene discussed is VIPR2; the disease is pancreatic ductal adenocarcinoma.